Journal for ImmunoTherapy of Cancer (Nov 2023)
728 A phase 1/2 study of JK08, an IL-15 antibody fusion protein targeting CTLA-4, in patients with advanced solid tumors
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)